These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21757356)

  • 41. Association of allelic loss at the FHIT locus and p53 alterations with tumour kinetics and chromosomal instability in non-small cell lung carcinomas (NSCLCs).
    Garinis GA; Gorgoulis VG; Mariatos G; Zacharatos P; Kotsinas A; Liloglou T; Foukas P; Kanavaros P; Kastrinakis NG; Vassilakopoulos T; Vogiatzi T; Field JK; Kittas C
    J Pathol; 2001 Jan; 193(1):55-65. PubMed ID: 11169516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer.
    Rohr UP; Rehfeld N; Geddert H; Pflugfelder L; Bruns I; Neukirch J; Rohrbeck A; Grote HJ; Steidl U; Fenk R; Opalka B; Gabbert HE; Kronenwett R; Haas R
    Clin Cancer Res; 2005 Jan; 11(1):180-5. PubMed ID: 15671544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Reduction of FHIT gene expression in primary lung cancer: relationship with the proliferation and apoptosis of tumor cell].
    Wang Y; Zhou Q; Zhang S; Yang H; Cheng N; Li L; Wu Z; Liu L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Jun; 18(3):178-82. PubMed ID: 11402444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FHIT alterations in breast cancer.
    Ingvarsson S
    Semin Cancer Biol; 2001 Oct; 11(5):361-6. PubMed ID: 11562178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Fragile Histidine Triad gene and breast cancer.
    Yang Q; Yoshimura G; Sakurai T; Kakudo K
    Med Sci Monit; 2002 Jul; 8(7):RA140-4. PubMed ID: 12118213
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding.
    Trapasso F; Krakowiak A; Cesari R; Arkles J; Yendamuri S; Ishii H; Vecchione A; Kuroki T; Bieganowski P; Pace HC; Huebner K; Croce CM; Brenner C
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1592-7. PubMed ID: 12574506
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stereochemical retention of the configuration in the action of Fhit on phosphorus-chiral substrates.
    Abend A; Garrison PN; Barnes LD; Frey PA
    Biochemistry; 1999 Mar; 38(12):3668-76. PubMed ID: 10090754
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel thiazolidine compound induces caspase-9 dependent apoptosis in cancer cells.
    Onen-Bayram FE; Durmaz I; Scherman D; Herscovici J; Cetin-Atalay R
    Bioorg Med Chem; 2012 Sep; 20(17):5094-102. PubMed ID: 22867707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fhit protein inhibits cell growth by attenuating the signaling mediated by nuclear factor-kappaB in colon cancer cell lines.
    Nakagawa Y; Akao Y
    Exp Cell Res; 2006 Aug; 312(13):2433-42. PubMed ID: 16733051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective monitoring of the enzymatic activity of the tumor suppressor Fhit.
    Hacker SM; Mortensen F; Scheffner M; Marx A
    Angew Chem Int Ed Engl; 2014 Sep; 53(38):10247-50. PubMed ID: 25098403
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluorimetric detection of enzymatic activity associated with the human tumor suppressor Fhit protein.
    Asensio AC; Oaknin S; Rotllán P
    Biochim Biophys Acta; 1999 Jul; 1432(2):396-400. PubMed ID: 10407161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fragile histidine triad-mediated tumor suppression of lung cancer by targeting multiple components of the Ras/Rho GTPase molecular switch.
    Jayachandran G; Sazaki J; Nishizaki M; Xu K; Girard L; Minna JD; Roth JA; Ji L
    Cancer Res; 2007 Nov; 67(21):10379-88. PubMed ID: 17974981
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ubc9-induced inhibition of diadenosine triphosphate hydrolase activity of the putative tumor suppressor protein Fhit.
    Golebiowski F; Szulc A; Szutowicz A; Pawelczyk T
    Arch Biochem Biophys; 2004 Aug; 428(2):160-4. PubMed ID: 15246872
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression and simple, one-step purification of fragile histidine triad (Fhit) tumor suppressor mutant forms in Escherichia coli and their interaction with protoporphyrin IX.
    Zawacka-Pankau J; Podhajska AJ
    Biotechnol Lett; 2007 Jun; 29(6):877-83. PubMed ID: 17310323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Small-Molecule Inhibitors of the Tumor Suppressor Fhit.
    Lange S; Hacker SM; Schmid P; Scheffner M; Marx A
    Chembiochem; 2017 Sep; 18(17):1707-1711. PubMed ID: 28643453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preclinical assessment of FHIT gene replacement therapy in human leukemia using a chimeric adenovirus, Ad5/F35.
    Pichiorri F; Trapasso F; Palumbo T; Aqeilan RI; Drusco A; Blaser BW; Iliopoulos D; Caligiuri MA; Huebner K; Croce CM
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3494-501. PubMed ID: 16740775
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells.
    Gaudio E; Paduano F; Ngankeu A; Ortuso F; Lovat F; Pinton S; D'Agostino S; Zanesi N; Aqeilan RI; Campiglia P; Novellino E; Alcaro S; Croce CM; Trapasso F
    Oncotarget; 2016 May; 7(21):29927-36. PubMed ID: 27166255
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential.
    Semba S; Trapasso F; Fabbri M; McCorkell KA; Volinia S; Druck T; Iliopoulos D; Pekarsky Y; Ishii H; Garrison PN; Barnes LD; Croce CM; Huebner K
    Oncogene; 2006 May; 25(20):2860-72. PubMed ID: 16407838
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Expression of fragile histidine triad (FHIT) protein and Ki-67 in transformed epithelial cells induced by Yunnan tin mine dust].
    Bian L; He YW; Fu HM; Ruan YH; Gao Q; Wang CY; Jin KW
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2010 Dec; 28(12):895-9. PubMed ID: 21241597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Activation state-dependent interaction between Gαq subunits and the Fhit tumor suppressor.
    Zuo H; Chan GP; Zhu J; Yeung WW; Chan AS; Ammer H; Wong YH
    Cell Commun Signal; 2013 Aug; 11():59. PubMed ID: 23947369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.